BUPRENORPHINANALOGA

Patent europeic · EP2326651 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP2326651
Numer da la dumonda
EP09789036
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
30-07-2009
Publitgà
01-06-2011
Concedì
27-11-2013
Stritgà
31-07-2017
Motiv
Taxa annuala betg pajada
Classas IPC
C07D 489/12 (2006.01)
A61K 31/485 (2006.01)
A61P 25/04 (2006.01)
Prioritad
US 226119 P 16.07.2009
US 84764 P 30.07.2008
Dumonda PCT
PCT/US2009/004391 30.07.2009
Publicaziun PCT
WO2010/014229 04.02.2010
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 21-02-2018

    Stritgà, taxa betg pajada

    Published in Swissreg on 21.02.2018

  2. 30-09-2016

    Adressa midada

    Representative
    Maiwald Patentanwaltsgesellschaft (Schweiz) mbH, Splügenstrasse 8, 8002 Zürich → Gottschalk Maiwald Patentanwalts- und Rechtsanwalts- (Schweiz) GmbH, Splügenstrasse 8, 8002 Zürich

    Published in Swissreg on 30.09.2016

  3. 03-12-2013

    Represchentant inscrit

    Representative
    Maiwald Patentanwaltsgesellschaft (Schweiz) mbH, Splügenstrasse 8, 8002 Zürich

    Published in Swissreg on 03.12.2013

  4. 27-11-2013

    Concedì

    Published in Swissreg on 27.11.2013

Partidas

Possessur

Purdue Pharma LP

One Stamford Forum 201 Tresser Boulevard, Stamford, CT 06901, US

Represchentant

Gottschalk Maiwald Patentanwalts- und Rechtsanwalts- (Schweiz) GmbH

Splügenstrasse 8, 8002 Zürich

Inventur

KYLE, Donald, J.

Newtown, PA 18940, US

GOEHRING, R., Richard

Dublin, PA 18917, US

FUNDYTUS, Marian, E.

Burlington, NJ 08016, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.